ART Advanced Research Technologies Snapshot
In the ART world, there are many ways of seeing. ART Advanced Research Technologies manufactures laser-based diagnostic imaging devices for the medical and pharmaceutical industries. ART's Optix device allows scientists to use molecular imaging technology to study live animal subjects. The company's SoftScan device is used to detect and diagnose breast cancer. Both use light, rather than X-rays or soundwaves, in their applications. It also makes Fenestra contrast imaging agents. ART's products are distributed through direct sales efforts and via a strategic alliance with GE Healthcare. The company restructured under bankruptcy protection and was acquired by private financial firm Dorsky Worldwide in 2009.